EP3810810
CANCER TREATMENT METHODS BASED ON TP53 MUTATION STATUS AND HYPERMUTATION STATUS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.6.2019EP published:
6.3.2024EP application number:
19745306.1
EPO information:
European Patent Register
Max expiry date:
17.6.2039
Title in English:
CANCER TREATMENT METHODS BASED ON TP53 MUTATION STATUS AND HYPERMUTATION STATUSLanguage of the patent:
English
Timeline
Today
18.6.2019EP application
6.3.2024EP Publication
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka 541-0045, JP
Inventor
Name:
OHASHI, AkihiroAddress:
Fujisawa-shi, Kanagawa 251-0012, JP
Name:
IWAI, KenichiAddress:
Fujisawa-shi, Kanagawa 251-0012, JP
Name:
NAMBU, TadahiroAddress:
Fujisawa-shi, Kanagawa 251-0012, JP
Name:
YAMANAKA, KazunoriAddress:
Fujisawa-shi, Kanagawa 2510012, JP
Name:
OTAKE, KentaroAddress:
Fujisawa-shi, Kanagawa 2510012, JP
Name:
NIU, HuifengAddress:
Cambridge, Massachusetts 02139, US
Name:
SHIN, HyunjinAddress:
Cambridge, Massachusetts 02139, US
Name:
KOENIG, Erik MichaelAddress:
Cambridge, Massachusetts 02139, US
Priority
Number:
201862686960 PDate:
19.6.2018Country:
US
Classification
Categories:
C12Q 1/6886, A61K 31/33, C07D 495/04, A61K 31/519, A61P 35/00